Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paclitaxel polymeric micelle - Shanghai Yizhong Pharmaceutical

Next Previous
X
Search
Drug Profile

Paclitaxel polymeric micelle - Shanghai Yizhong Pharmaceutical

Alternative Names: Paclitaxel polymeric micelle for injection - Shanghai Yizhong Bio-technology; Paclitaxel polymeric micelle for injection - Shanghai Yizhong Pharmaceutical

Latest Information Update: 07 Jan 2025

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Yizhong Bio-technology
  • Class Albumins; Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Breast cancer

Most Recent Events

  • 02 Jan 2025 Shanghai Yizhong Pharmaceutical plans a phase III pompom trial for Pancreatic cancer (Metastatic disease, First-line therapy, Combination therapy) in China (IV) in January 2025 (NCT06752811)
  • 25 Nov 2023 Phase-III clinical trials in Breast cancer (Second-line therapy or greater, Metastatic disease, Recurrent) in China (IV) (NCT06143553)
  • 02 Jul 2014 Shanghai Yizhong Pharmaceutical has patent protection for "Polymer micelle lyophilized agent encapsulating insoluble antitumor drug" in China

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top